Hepatitis C News
Week Ending June 28, 2021

Hepatitis C Screening: What to Know
“Chronic hepatitis C is often asymptomatic, meaning many people don’t know they have it. Unlike hepatitis A and hepatitis B, there’s no vaccine that protects you against hepatitis C. That’s why screening is so important, especially for at-risk people.”

The liver, we can’t live without it
“The liver is one of the most amazing but underrated organs in our bodies. We cannot live without it, and, unlike the kidney, we cannot bypass it with a dialysis machine. Lose your liver and you lose your life.”

Examining Why Patients With Chronic Hepatitis C Drink Alcohol
“The burden of chronic liver disease in the United States is substantial, affecting about 4.5 million American adults, according to recent data. The end result of chronic liver disease is cirrhosis, which can lead to deaths from infections, hemorrhage, renal failure, and liver cancer. Chronic hepatitis C infection (HCV) and alcoholic liver disease have contributed significantly to doubling the burden of cirrhosis in the US during the past 10 years.”

Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt
“Self-testing for hepatitis C virus antibodies (HCVST) may be an additional strategy to expand access to hepatitis C virus (HCV) testing and support elimination efforts. We conducted a study to assess the usability and acceptability of HCVST among the general population in a semi-rural, high-HCV prevalence region in Egypt.”

We Treat Hep C Initiative: MDHHS partners with professional consultation programs to offer free hepatitis C training and resources for health care providers
“The Michigan Department of Health and Human Services (MDHHS) launched the We Treat Hep C Initiative on April 1, 2021 as a key strategy to eliminate hepatitis C virus (HCV) as a health threat to Michiganders.”

Improving Outcomes for Homeless People With HIV and Hepatitis C
“An intensive, low-barrier HIV care program helped vulnerable people experiencing homelessness or unstable housing stay on antiretroviral treatment and achieve viral suppression, according to a study published in AIDS. A related study found that offering testing and treatment in temporary hotels during COVID-19 improved outcomes for homeless people with hepatitis C.”

What Are the Treatment Options for Autoimmune Hepatitis?
“Hepatitis is an inflammatory condition that can develop with or without a viral infection. In the case of autoimmune hepatitis, the body’s immune system mistakenly attacks healthy liver cells. This can lead to cirrhosis or even liver failure if the condition isn’t treated effectively.”

WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination
“New WHO Guidance for country validation of viral hepatitis B and C elimination is released during a joint EASL-CDC-ECDC and WHO symposium “Viral Hepatitis Elimination – Assessing the progress in 2021” at the EASL International Liver Congress 2021. This represents the first-ever global guidance for countries seeking to validate elimination of hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection as a public health problem.”

Researchers call for immediate treatment without restriction in hepatitis C
“Researchers called for immediate treatment action without restriction among patients with hepatitis C for continued progress in virus elimination following COVID-19, according to a presentation at the International Liver Congress.”

Here Are the Top Signs of Liver Cancer—Plus Everything You Need to Know About Screening and Treatment 
“The liver is one of the hardest-working organs in your body and has many life-sustaining functions. And, health experts say everyone should care about liver health, especially as cases of liver cancer have been on the rise in the U.S. over the past few decades.”

Is the Availability of Direct-Acting Antivirals Associated with Increased Access to Hepatitis C Treatment for Homeless and Unstably Housed Veterans?
“Hepatitis C virus (HCV) treatment has experienced a rapid transformation in the USA. New direct-acting antiviral (DAA) medications make treatment easier, less toxic, and more successful (90% or greater viral cure) than prior, interferon-based HCV medications. We sought to determine whether DAAs may have improved access to HCV treatment for hard-to-reach populations such as the homeless.”